Cheryl Wiley
Family Medicine · Anderson, CANPI 1417003906
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 124 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by AbbVie at 43.1% of the total. Reporting peaked in 2021 at $849 and has fallen 94.0% since, to $51 in 2025.
Across 124 payments — averaging $16.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$887
- Daiichi Sankyo Inc.$244
- Myovant Sciences Inc.$162
- Exact Sciences$150
- Pfizer$126
- Organon$103
- plus $386 from 11 others
What the payments were for
- Food & beverage$2,058100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 56 | $887 |
| Daiichi Sankyo Inc. | 18 | $244 |
| Myovant Sciences Inc. | 11 | $162 |
| Exact Sciences | 8 | $150 |
| Pfizer | 5 | $126 |
| Organon | 5 | $103 |
| Astellas Pharma US Inc | 3 | $74 |
| Therapeuticsmd, Inc. | 3 | $69 |
| Sumitomo Pharma America, Inc. | 3 | $68 |
| Mayne Pharma Commercial LLC | 4 | $37 |
| Hologic Sales And Service, LLC | 2 | $32 |
| Bayer | 1 | $24 |
| Roche Diagnostics Corporation | 1 | $21 |
| Evofem Biosciences, Inc. | 1 | $17 |
| Baxter Healthcare | 1 | $16 |
| Merck | 1 | $15 |
| Aspira Women's Health Inc | 1 | $13 |
How this compares
$2,058 in reported general payments places this provider in the 80th percentile of 10,533 family medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 66 | $8,394 |
| IntrarosaPrasterone (Dhea) | 11 | $2,819 |
| DottiEstradiol | 13 | $2,365 |
| ValacyclovirValacyclovir Hcl | 15 | $1,002 |
| ProgesteroneProgesterone, Micronized | 21 | $772 |
| Risedronate Sodium | 12 | $146 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Anderson
- Sherly SoleimanEncino$1.2M
- Pamela KushnerLos Angeles$1.2M
- Sujata NarayanStanford$1.2M
- Jeffrey UngerChino$906K
- Alexander RivkinLos Angeles$866K
- Scott HowellLos Angeles$793K
- Derrick ButlerLos Angeles$692K
- Sandra CalmanMontara$589K
- Anthony JonesOakland$377K
- Amira AyadBakersfield$360K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.